Table 1.
Compound | Yeast glucocorticoid assay | GR-CALUX | ||
---|---|---|---|---|
EC50 (μM) | RCP | EC50 (nM) | RCP | |
Dexamethasone | 120 | 1.0 | 2.2 | 1.0 |
Budesonide | 6 | 20 | 2.2 | 1.0 |
Betamethasone | 149 | 0.8 | 11 | 0.2 |
Cortisol | 123 | 1.0 | 37 | 0.06 |
Corticosterone | 71 | 1.7 | 80 | 0.03 |
Cortisone | Not active | 0.0 | Not active | 0 |
Aldosterone | 705 | 0.2 | 495 | 0.004 |
Fludrocortisone-21-acetate | Not active | 0.0 | 11 | 0.2 |
Prednisolone | 643 | 0.2 | 12 | 0.2 |
Prednisone | Not active | 0.0 | Not active | 0 |
Triamcinolone | Activea | Active | 19 | 0.1 |
Mifepristone | 578 | 0.2 | Not activeb | 0 |
17β-Estradiol (E2) | Not active | 0.0 | Not active | 0 |
5α-Dihydrotestosterone | Not active | 0.0 | Not active | 0 |
Progesterone (P4) | Activea | Active | Activea | Active |
aTriamcinolone and progesterone are slightly active in the yeast bioassay, but their maximal responses are only about 10% and 6%, respectively, of the maximal response as obtained with dexamethasone; thus, it is not appropriate to give an EC50 value or RCP. Progesterone is also active in the GR-CALUX, but its response is only about 4% of the maximal response as obtained with dexamethasone
bMifepristone is not active as an agonist in the GR-CALUX and acts as a pure antagonist in this assay